The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
The acquisition will establish a new modality for drug discovery and development at Lilly ... Dec 15
Fewer species and high numbers of particular bacteria linked to heightened risk ... Dec 15
-Advertisements-